Screener/Healthcare/Biotechnology

NKTR

Nektar TherapeuticsNASDAQ
$73.02-1.24 (-1.66%)
Small CapHealthcare
$6.48
$77.00
$70.67
$73.93
EPS (TTM)$-5.02
P/E Ratio—
Dividend Yield—
Market Cap$1.41B
Volume576K
Prev Close$74.34
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$11.8M-$35.5M$-1.87—-301.3%
Q2 '25$11.2M-$41.6M$-2.95—-372.2%
Q1 '25$10.5M-$50.9M$-0.24—-486.4%
Q4 '24$29.2M$7.3M$0.0472.7%24.9%
Q3 '24$24.1M-$37.1M$-0.1881.6%-153.6%
Q2 '24$23.5M-$52.4M$-0.2558.5%-222.9%
Q1 '24$21.6M-$36.8M$-0.1960.6%-170.1%
Q4 '23$23.9M-$42.1M$-0.2269.5%-176.2%
Get Your Daily Market Recap